Spreadsheets vs EDC: Real Cost Comparison for MedTech Clinical Studies

Spreadsheets look harmless. You already own Excel, your team knows how to use it, and you can build a tracker in an afternoon, add a few tabs, and send it out to your sites. Paper feels similar: print the case report forms, collect the data, scan the pages, and key everything in later. For a lean medtech team trying to move quickly, that practicality is appealing. Why pay for an electronic data capture (EDC) system when the tools on hand seem to do the job?

The question misses what actually costs money in a regulated clinical study. The expense lives in the work of getting from first subject enrolled to clean, complete, traceable, audit-ready data, and that work means months of manual review, monitoring follow-up, query reconciliation, and late-stage cleanup. Clinical data management covers collecting, reviewing, and preparing study data so the results hold up under regulatory and good clinical practice scrutiny, and how a sponsor manages that data can matter as much as the trial design itself. So the better question is not whether Excel is cheaper than EDC, but what mistakes in your data management will cost you.

Why paper and spreadsheets look cheaper than EDC

Paper and spreadsheets win the first cost comparison because their visible costs are low. No software subscription, no vendor implementation, no procurement process, no formal study build. For lean teams, that is attractive.

But visible cost is a fraction of the total. The number that matters is the operational cost of collecting, reviewing, correcting, monitoring, locking, and defending the data. You may not pay for a spreadsheet upfront, but you still pay to build forms, manage versions, train sites, review data, track queries, reconcile files, prepare for audits, clean data, and fix mistakes that surface late in the study.

None of this makes Excel useless. It is an excellent general-purpose tool for planning, budgeting, forecasting, and internal tracking. The trouble starts when a spreadsheet becomes the primary infrastructure for regulated clinical data.

The real cost categories in clinical data collection

When you compare spreadsheets, paper, and EDC, compare the full clinical data workflow rather than software cost alone. A realistic comparison accounts for the tool itself, study setup, site training, data entry, edit checks and validation, monitoring, query management, reconciliation, audit preparation, and the business cost of a delayed timeline. A spreadsheet is cheap to open. It is rarely cheap to operate.

The table below lays out where each approach carries cost.

The point is not that EDC is free, because it carries real cost. Paper and spreadsheets carry costs too. Theirs simply hides in labor, rework, monitoring burden, delayed visibility, and audit preparation.

When a spreadsheet can hold clinical data, and when it can't

Spreadsheets support some clinical workflows well, especially planning, forecasting, operational tracking, and low-risk internal analysis. They turn risky as the primary system for clinical data capture, monitoring, query management, audit trails, electronic signatures, or submission-critical data.

A spreadsheet can hold clinical data. The harder question is whether it can support the controls around that data. In an FDA-regulated environment, electronic records and signatures may need to meet the criteria in 21 CFR Part 11 to be considered trustworthy and generally equivalent to paper records and handwritten signatures. Part 11 also requires secure, computer-generated, time-stamped audit trails that record entries and changes without obscuring previous information.

That is a high bar for an uncontrolled spreadsheet. A team could build the procedures, permissions, validation documentation, and review processes to clear it. At that point, though, the honest question is whether they are saving money or rebuilding an EDC system by hand.

What an EDC system does that a spreadsheet doesn't

Spreadsheets store data. EDC systems manage the clinical data workflow. That is the cleanest way to describe the difference.

A spreadsheet can hold subject IDs, visit dates, lab values, adverse event logs, enrollment trackers, and site notes. What it does not provide is the process around those values: controlled eCRF design, role-based permissions, built-in edit checks, required fields, structured query workflows, real-time monitoring, audit trails, electronic signatures, and controlled versioning across users and sites.

An EDC system is built to run a study, not just to store its data. Greenlight Guru Clinical, for example, provides electronic data collection, eCRF, ePRO/eCOA, eConsent, randomization, post-market clinical follow-up (PMCF) surveys, adverse event reporting, API support, audit trails, Part 11-compliant e-signatures, and workflows aligned with FDA, EU MDR, and ISO 14155:2020 requirements.

Why Excel gets risky as the system of record

Regulated studies need more than data entry. They need controlled access, version control, traceability, edit checks, query workflows, monitoring visibility, audit trails, and reliable exports. Without those controls, spreadsheets create rework, delay closeout, and introduce audit-readiness problems. The risk tends to cluster in a few predictable places.

Version control. Anyone who has worked from shared spreadsheets knows the pattern. Someone downloads a file, renames it, edits a local copy, or emails a new version without copying the full team. A site works from an outdated template. Soon no one can say with confidence which version is final, who changed a given value, when it changed, or whether the prior value was preserved. Those gaps are merely annoying in general business operations. In clinical data management they become compliance problems.

Data integrity. The flexibility that makes spreadsheets pleasant also makes them fragile. Cells get overwritten, formulas break, values land in the wrong field, units vary, required fields get skipped, and changes happen without a complete record. A small internal tracker can absorb that. A regulated study cannot.

Monitoring. When data lives in files, attachments, scanned forms, and trackers, the study team assembles status by hand: which forms are complete, which subjects have missing visits, which sites are behind, which queries are open, and which adverse events still need follow-up. The answers exist. They are just scattered across half a dozen places.

Transcription and paper. Paper adds its own tax. Data collected on paper usually has to be re-entered for review, cleaning, and analysis, and every transcription step is a fresh chance for error. The sponsor often can't see the true status of a subject or site until documents are scanned, shipped, entered, and reconciled. The riskiest setup combines both worlds: paper at the site, spreadsheets at the sponsor, email for queries, and shared folders for documents. That creates two points of failure and several competing versions of the truth.

Timeline. Each of these problems delays work that should happen continuously. Data review waits for file transfers, query resolution waits for a tracker update, and database lock waits for manual reconciliation. The delay rarely comes from one big failure. It accumulates across hundreds of small manual steps.

What spreadsheet workflows actually cost

The honest way to model spreadsheet and paper cost is to add up the labor, not the license. Setup, site training, data entry, transcription, review, query management, monitoring, data cleaning, reconciliation, and audit preparation all consume hours, and so do the study delays and rework that follow.

Teams underestimate this number because no line item says "spreadsheet cost." It shows up as a project manager chasing site updates, a data manager reconciling duplicate files, a monitor reviewing incomplete forms, and a clinical research associate (CRA) tracking queries by email. A quality and regulatory team assembles audit evidence late. A statistician waits on cleaner exports. The sponsor delays database lock because open questions remain.

That is the real comparison: not an Excel license against an EDC subscription, but manual clinical data management against a controlled one. And it grows more lopsided as studies scale. A five-site study with 100 subjects, six visits each, multiple forms per visit, protocol amendments, adverse event follow-up, and PMCF surveys is not a lean spreadsheet process. It is a distributed, mostly invisible workload.

Where EDC changes the cost curve

EDC lowers cost by removing manual work and heading off downstream problems, not by undercutting an Excel license. Forms can be structured so required fields, ranges, formats, and response logic are enforced at the point of capture, which keeps errors from traveling into review and cleaning. Centralized data lets a sponsor see study progress without emailing a site for basic status. Queries attach directly to the data point in question rather than living in a separate email thread, which makes them easier to resolve and to defend. Audit readiness becomes a property of how the study runs, since records, permissions, signatures, and reviews are controlled as the work happens instead of reconstructed before an inspection.

Lifecycle coverage matters too. Clinical evidence shows up at feasibility, first-in-human, pivotal investigations, post-market surveillance, PMCF, registries, and long-term follow-up. Greenlight Guru Clinical is built for that full range, with collection methods including eCRF, ePRO, patient surveys, and clinician-reported outcomes, alongside the audit trails, Part 11-compliant e-signatures, and ISO 14155-aligned workflows a regulated study needs.

When spreadsheets are the right tool

None of this means avoiding Excel entirely. Spreadsheets earn their place in enrollment forecasting, budgeting, internal planning, site feasibility tracking, early study scoping, and exploratory analysis that isn't the controlled system of record. The guideline is simple: keep spreadsheets around the study, not at its center.

They become the wrong tool the moment they carry regulated work, including primary clinical data capture, subject-level data, eCRF data, adverse event and protocol deviation logs, query management, multi-site collection, PMCF data, submission-critical evidence, electronic signatures, audit trails, and database lock.

Choosing between EDC, paper, and spreadsheets

EDC is the right choice when you are collecting subject-level clinical data, running a multi-site study, expecting protocol amendments, capturing adverse event data, preparing for regulatory submission, or running a PMCF study or registry. The same holds when you need audit trails, electronic signatures, real-time monitoring, structured query management, clean exports, or sponsor oversight across sites and CROs.

Spreadsheets work as supporting tools only when the data is not regulated source data, the spreadsheet is not the system of record, the workflow is low risk, and appropriate controls are in place. Use paper only when there is a clear operational reason to do so, and only with a plan for transcription, verification, review, and reconciliation.

The most expensive option is rarely the one with the highest sticker price. It is usually the one that forces your team to find and fix preventable problems after they have already slowed the study down.

How Greenlight Guru Clinical helps medtech teams move past spreadsheets

Medical device studies do not look like pharmaceutical trials. The designs differ, the endpoints differ, the teams run leaner, and the data often has to serve regulatory submission, post-market surveillance, PMCF obligations, and long-term evidence at the same time. That calls for clinical data tools built for how medtech teams actually work.

Greenlight Guru Clinical is built specifically for medical device clinical studies, supporting electronic data collection, eCRFs, ePRO/eCOA, eConsent, randomization, PMCF surveys, adverse event reporting, APIs, audit trails, and electronic signatures in a centralized, validated system. Teams running on it spend less time chasing files and reconciling data, get clearer visibility into study progress, and reach database lock with cleaner data and stronger audit readiness.

For teams ready to replace spreadsheet-driven workflows, explore Greenlight Guru's EDC software for medical device clinical trials and clinical data management software for medtech.